On March 31, the U.S. Food and Drug Administration (FDA) Mylan’s voluntary recall of the popular EpiPen brand of auto-injector medical device used to treat patients with severe allergies. This announcement came nearly two weeks after a similar recall was issued for the same devices in seven other countries. The recalls were a direct response to consumer complaints that the devices failed to operate as marketed.… Read More